- Home
- WKC vs SPRY Comparison
WKC vs SPRY Comparison
Compare WKC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- SPRY
- Stock Information
- Founded
- WKC 1984
- SPRY 2015
- Country
- WKC United States
- SPRY United States
- Employees
- WKC N/A
- SPRY N/A
- Industry
- WKC Oil Refining/Marketing
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- WKC Energy
- SPRY Health Care
- Exchange
- WKC Nasdaq
- SPRY Nasdaq
- Market Cap
- WKC 1.7B
- SPRY 1.4B
- IPO Year
- WKC N/A
- SPRY N/A
- Fundamental
- Price
- WKC $29.00
- SPRY $13.02
- Analyst Decision
- WKC Hold
- SPRY Buy
- Analyst Count
- WKC 5
- SPRY 5
- Target Price
- WKC $28.00
- SPRY $22.25
- AVG Volume (30 Days)
- WKC 623.6K
- SPRY 1.3M
- Earning Date
- WKC 10-24-2024
- SPRY 11-07-2024
- Dividend Yield
- WKC 2.35%
- SPRY N/A
- EPS Growth
- WKC 20.89
- SPRY N/A
- EPS
- WKC 2.25
- SPRY N/A
- Revenue
- WKC $46,164,900,000.00
- SPRY $500,000.00
- Revenue This Year
- WKC N/A
- SPRY $14,196.67
- Revenue Next Year
- WKC $4.49
- SPRY $1,212.94
- P/E Ratio
- WKC $12.89
- SPRY N/A
- Revenue Growth
- WKC N/A
- SPRY 128.31
- 52 Week Low
- WKC $17.69
- SPRY $2.55
- 52 Week High
- WKC $29.16
- SPRY $16.50
- Technical
- Relative Strength Index (RSI)
- WKC 58.31
- SPRY 56.79
- Support Level
- WKC $27.62
- SPRY $11.27
- Resistance Level
- WKC $29.16
- SPRY $12.03
- Average True Range (ATR)
- WKC 0.54
- SPRY 0.67
- MACD
- WKC -0.01
- SPRY -0.11
- Stochastic Oscillator
- WKC 70.69
- SPRY 60.96
About WKC World Kinect Corporation
World Kinect Corp is a energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers . It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. Company operate in three reportable segments consisting of aviation, land, and marine. Company earn majority of revenue from Aviation segment.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.